Related references
Note: Only part of the references are listed.Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort
Stanislas Pol
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
Jin-Lin Hou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China
Terry Cheuk-Fung Yip et al.
GASTROENTEROLOGY (2020)
Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection
Ming-Lun Yeh et al.
JOURNAL OF HEPATOLOGY (2020)
Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential
Yuchen Xia et al.
ANTIVIRAL RESEARCH (2020)
RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma
Xuejing Huang et al.
CANCER SCIENCE (2020)
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2020)
Phosphorylation of the Arginine-Rich C-Terminal Domains of the Hepatitis B Virus (HBV) Core Protein as a Fine Regulator of the Interaction between HBc and Nucleic Acid
Hugues de Rocquigny et al.
VIRUSES-BASEL (2020)
Hepatitis B Vaccine: Assessment of Immunologic Response, Coverage Rate, and Factors Influencing Seroreactivity
Abdullah Khafagy et al.
CLINICAL LABORATORY (2020)
Ccne1 Overexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in Mice
Khaled Aziz et al.
GASTROENTEROLOGY (2019)
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Fabrice Carrat et al.
LANCET (2019)
Occult hepatitis B virus and surface antigen mutant infection in healthy vaccinated cohorts and children with various forms of hepatitis and multiple transfusions
Wei-Li Hung et al.
LIVER INTERNATIONAL (2019)
Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment
Kazuo Tarao et al.
CANCER MEDICINE (2019)
The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis
Zeyu Zhang et al.
BMC CANCER (2019)
Viral hepatitis in children and adolescents 1 Hepatitis B virus infection in children and adolescents
Giuseppe Indolfi et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load
Tai-Chung Tseng et al.
GASTROENTEROLOGY (2019)
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B A Korean Nationwide Cohort Study
Jonggi Choi et al.
JAMA ONCOLOGY (2019)
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
Barbara Testoni et al.
JOURNAL OF HEPATOLOGY (2019)
HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues
Terry Cheuk-Fung Yip et al.
JOURNAL OF HEPATOLOGY (2019)
the prevention of hepatitis B-related hepatocellular carcinoma
C. -L. Lin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
Jung Hwan Yu et al.
HEPATOLOGY RESEARCH (2018)
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B
G. Jourdain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma
Ping An et al.
FRONTIERS IN GENETICS (2018)
Implementation of hepatitis B vaccine in high-risk young adults with waning immunity
Nawarat Posuwan et al.
PLOS ONE (2018)
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection
L. -Y. Mak et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Fasiha Kanwal et al.
GASTROENTEROLOGY (2017)
Increasing Burden of Liver Cancer Despite Extensive Use of Antiviral Agents in a Hepatitis B Virus-Endemic Population
Jonggi Choi et al.
HEPATOLOGY (2017)
The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B
George V. Papatheodoridis et al.
HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy
K. -S. Cheung et al.
JOURNAL OF VIRAL HEPATITIS (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame
Pierluigi Ramadori et al.
CANCERS (2017)
The negative impact of HBV/HCV coinfection on cirrhosis and its consequences
S. Pol et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study
Joseph Ahn et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease
Noele P. Nelson et al.
CLINICS IN LIVER DISEASE (2016)
Visualization of hepatitis B virus entry - novel tools and approaches to directly follow virus entry into hepatocytes
Zhenfeng Zhang et al.
FEBS LETTERS (2016)
Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
Mei-Hwei Chang et al.
GASTROENTEROLOGY (2016)
British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015
Anna Maria Geretti et al.
HIV MEDICINE (2016)
Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination
Arezoo Aghakhani et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2016)
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
Jeffrey D. Stanaway et al.
LANCET (2016)
Requirements for global elimination of hepatitis B: a modelling study
Shevanthi Nayagam et al.
LANCET INFECTIOUS DISEASES (2016)
Eliminating hepatitis B virus as a global health threat
Grace Lai-Hung Wong et al.
LANCET INFECTIOUS DISEASES (2016)
Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis
Elena Raffetti et al.
LIVER INTERNATIONAL (2016)
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Tung-Hung Su et al.
LIVER INTERNATIONAL (2016)
Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants' vaccination against hepatitis B in general and pediatric practices - the PRALINE study
F. Vie le Sage et al.
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE (2016)
Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma
Cheng Zhang et al.
ONCOTARGET (2016)
Role of alcohol in the development and progression of hepatocellular carcinoma
Iain H. McKillop et al.
HEPATIC ONCOLOGY (2016)
Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
W. Ray Kim et al.
CANCER (2015)
O Alcohol consumption and liver cancer risk: a meta-analysis
Shu-Chun Chuang et al.
CANCER CAUSES & CONTROL (2015)
Oncogenic potential of hepatitis B virus encoded proteins
Marc Ringelhan et al.
CURRENT OPINION IN VIROLOGY (2015)
A new vaccine escape mutant of hepatitis B virus causes occult infection
Qing Ye et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
C-terminal-truncated hepatitis B virus X protein enhances the development of diethylnitrosamine-induced hepatocellular carcinogenesis
Ivan Quetier et al.
JOURNAL OF GENERAL VIROLOGY (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Hepatitis D and hepatocellular carcinoma
Zaigham Abbas et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Risk Prediction of Hepatocellular Carcinoma in Patients With Cirrhosis: The ADRESS-HCC Risk Model
Jennifer A. Flemming et al.
CANCER (2014)
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
Yi Ni et al.
GASTROENTEROLOGY (2014)
Telomerase Reverse Transcriptase Promoter Mutation Is an Early Somatic Genetic Alteration in the Transformation of Premalignant Nodules in Hepatocellular Carcinoma on Cirrhosis
Jean Charles Nault et al.
HEPATOLOGY (2014)
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications
Teresa Pollicino et al.
JOURNAL OF HEPATOLOGY (2014)
Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled Trial
Chunfeng Qu et al.
PLOS MEDICINE (2014)
Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
A. K. Singal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Long-term Efficacy and Safety of Lamivudine, Entecavir, and Tenofovir for Treatment of Hepatitis B Virus-Related Cirrhosis
Seyfettin Koklu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan
Chun-Ju Chiang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naive patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma
Meirong Wang et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Efficacy of HBV Vaccination in Various Stages of Chronic Kidney Disease: Is Earlier Better?
Behnam Hashemi et al.
Hepatitis Monthly (2012)
Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine
Benjamin P. Sablan et al.
VACCINE (2012)
Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients
F. Fabrizi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The worldwide impact of vaccination on the control and protection of viral hepatitis B
Luisa Romano et al.
DIGESTIVE AND LIVER DISEASE (2011)
Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma
Chuen-Fei Chen et al.
GASTROENTEROLOGY (2011)
Elimination of Hepatocellular Carcinoma and Acute Hepatitis B in Children 25 Years After a Hepatitis B Newborn and Catch-Up Immunization Program
Brian J. McMahon et al.
HEPATOLOGY (2011)
Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1 A Randomized Controlled Trial
Odile Launay et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Hepatitis B surface antigen quantification: Why and how to use it in 2011-A core group report
Henry Lik-Yuen Chan et al.
JOURNAL OF HEPATOLOGY (2011)
Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: Results of two open, randomized, comparative trials
Christian L. Tielemans et al.
VACCINE (2011)
Hepatitis B virus infection and the risk of hepatocellular carcinoma
Ya-Jun Tan
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals
Michael L. Landrum et al.
AIDS (2010)
Molecular genesis of drug-resistant and vaccine-escape HBV mutants
Stephen A. Locarnini et al.
ANTIVIRAL THERAPY (2010)
Potential threat of drug-resistant and vaccine-escape HBV mutants to public health
Chong-Gee Teo et al.
ANTIVIRAL THERAPY (2010)
Effect of Aging on Risk for Hepatocellular Carcinoma in Chronic Hepatitis C Virus Infection
Yasuhiro Asahina et al.
HEPATOLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Mechanisms of HBV-related hepatocarcinogenesis
Christine Neuveut et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatitis B vaccines: Protective efficacy and therapeutic potential
M. -L. Michel et al.
PATHOLOGIE BIOLOGIE (2010)
Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand
Yong Poovorawan et al.
VACCINE (2010)
The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature
Seyed-Moayed Alavian et al.
VACCINE (2010)
Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis
Jalal Poorolajal et al.
VACCINE (2010)
A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
Raffaella Romeo et al.
GASTROENTEROLOGY (2009)
Efficacy of Hepatitis B Vaccine Against Antiviral Drug-Resistant Hepatitis B Virus Mutants in the Chimpanzee Model
Saleem Kamili et al.
HEPATOLOGY (2009)
Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22-Year Follow-Up Study and Response to a Booster Dose
Brian J. McMahon et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden
V. T. T. Nguyen et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients
Mario Cruciani et al.
VACCINE (2009)
Hepatitis B vaccine responses in a large US military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count
Michael L. Landrum et al.
VACCINE (2009)
Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
J. J. Y. Sung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years
C. L. Cooper et al.
CLINICAL INFECTIOUS DISEASES (2008)
Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons
H. Nina Kim et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2008)
High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma
Henry Lik-Yuen Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment
Chi-Jen Chu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
Giovanna Fattovich et al.
JOURNAL OF HEPATOLOGY (2008)
A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients
N. C. T. Kong et al.
KIDNEY INTERNATIONAL (2008)
The global impact of vaccination against hepatitis B: A historical overview
Alessandro R. Zanetti et al.
VACCINE (2008)
Natural history of hepatitis-related hepatocellular carcinoma
David Yiu-Kuen But et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response
Henry Lik-Yuen Chan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Risk and predictors of mortality associated with chronic hepatitis B infection
Uchenna H. Iloeje et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
New hepatitis B vaccine formulated with an improved adjuvant system
Michael Kundi
EXPERT REVIEW OF VACCINES (2007)
Hepatitis B virus genotypes in Alaska native people with hepatocellular carcinoma: Preponderance of genotype F
Stephen E. Livingston et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma
Danny Ka-Ho Wong et al.
JOURNAL OF HEPATOLOGY (2006)
Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease
F. Fabrizi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Long-term protection against carriage of hepatitis B virus after infant vaccination
MAB van der Sande et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population
F Fabrizi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine
P Rendi-Wagner et al.
VACCINE (2006)
Natural history of compensated cirrhosis in the Child-Pugh Class A compared between 490 patients with hepatitis C and 167 with B virus infections
M Kobayashi et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy
S Franceschi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines
JN Zuckerman
JOURNAL OF MEDICAL VIROLOGY (2006)
Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination
T Bauer et al.
VACCINE (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis
D. Kremsdorf et al.
ONCOGENE (2006)
Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions
K Titanji et al.
AIDS (2005)
A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis
YL Liu et al.
VACCINE (2005)
Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose
MO Fonseca et al.
VACCINE (2005)
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
HB El-Serag et al.
GASTROENTEROLOGY (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Hepatitis B vaccine - do we need boosters?
JE Banatvala et al.
JOURNAL OF VIRAL HEPATITIS (2003)
The effect of age on immunologic response to recombinant hepatitis B vaccine: A meta-analysis
DN Fisman et al.
CLINICAL INFECTIOUS DISEASES (2002)
Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus
MM Hassan et al.
HEPATOLOGY (2002)
Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres
P Dentico et al.
VACCINE (2002)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis
T Ishikawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Hepatitis B vaccination and the risk of multiple sclerosis
A Ascherio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives
MW Yu et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load
D Rey et al.
VACCINE (2000)
Share Paper
